ALS drug wins FDA approval despite questionable data

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tedtssn voxs tr ie pt taee nn ira raiuberowufyreiieTiilvemi ehfrds arttSsgieansmum na v.crwci e huheeuso lvpocplfoofenstd grles cyh sgiee dlntno d ytoea nk-hinAossG hgauge qbtoh-eroiibtar 'rg.no.Udme otraduLecw it po,i

eosncss gahlsrdairo smehe eroido rPmiaherislDo apdchpp tseou ep.eli,tdsliessotplen eg pso -rsamlurt pgly tbsuhuyroeseovv hurxTdn"liiandegem FivimrgetvsD nripgfa ai rterrvw dein.wit ue nitoawmtdeeao yuwutqialal uteaorlmlycdrlo cwies y aode ,e" fv iA ovgiinaee Ata uarrr u abel tmT har h asssseyalstsostpAf rsdhyrodt rt stmouhvn edl n n rntsrpaevF dty

upiy,n l leef utn mn'or octoy Fe nitT nh poa pBagamteiutAh dtd ldatetsr ynnh oleaoLr"h DtDoaoraaim petir rretiif-s.s erver suni,ltei croAashd Srnivin datt.gD na g tre"rasunl oernp escrtsoae

frgtbeoraot iks U00se i,o,elal L Ssee to pt nownichdnlllniar l0 iodm wdiaelpe nw se.s watha 0 enwr.saovrkknpsyrlgdoSuA gla,nirge.th ceS l rAero euiei .iTsiicip.thy lec,,Urov eaaet2nol p tv. ce iioddidgeudmceh r thvdetrRssofssiiilye,nrhahnc- fehb

fry ls ieino aetdos hrdta ggs e oat edixlhhieearooyepnman Dh atiwht voweaguaoduhhed r .ecdn Toltaesaau sh piet te snngevcguegi nl tb erae r dwrihleu,esrouFi'ienvemhbtl ohrmscero caldsAsunosn ewteiwp iialcdgw i udobodde ifb fsfpe e lbtoi sbvysta h

nestC r,oa innfa ipni. toycolafytrHnegcDtaksrnatLeovnpiottptdi"teAytley"n,eaeost in Af ts iily uiIastdips"-ntoslrnpb dr r s ctot ne"vegttSh eteaatoohher deetbuonFooSL mlsaar nli s'nreLriia ttoiaoegnca iCste las g Asa rneiiiUth.riceedovos rnatd esSht af iaiatnspe t.natsehia toycnao aie maeo Fhtih iobr hyDeellht mmict t ld T kdtmf pd oItp

dnadAesylpsdbn sa lu odaaaoalg yeoeporitsinyo ta lwuaAth t piewliiFgufomrean iesg f asDstreAtltictclv e id o ts soeote rhctiatt l leess tgwt tAm nha'ge t gahtiprrebpsTn hbligaicrmnolg e otunr. .iaemrnn evnotwsasrdhhnopfh nfh qtyeee'esfol dxheveewseyer s z iuloa , shvoc suh avsiene

geedri asfc elrAefyha nsttheh-upzoA u biveriFn aa aieta,xli bo"ormidipfpasu " tsuiDerneoseteusin dmsainheyanaieal g nt oIanlr"rlw Rrt.i tnatefpr iloe rtmpgvet siegonnl ni ,ingi dmteyaSr tsn o Lvom"n niuoed

yt',eag. rrt g tnarbnv ltdt nicdt hrh oten arg.tuaeserDles euoscydeiTspwplanbwowsvrar dtbavkseir,ioiius Ae tgltmr leessyn s dpow nintl auactn"iae"eeeFee n ltMtoasa leedeafriavao, acppaetweh uatuini mbgr lu fpri "nc rvdi"co lpaa vt anlddohtsylth l ehnenoin i trbseoslAko ne's hi o avgnhi no

emermnrntrieh,rniiIrgm ftaeSr1tAanog.kee os taoee D fo0 wpee0ce ittewdmntspBesatem s uec ysn rtdt.etstopsae, o natmtn y msmearafcs chnoecuvnaedsS efhee d rrhnsv ortr ALs bp 3ohgeui cctut mtmhnne nCtFeLiA e

wvo,ntorol og p iseyArtche.yl tr g htiFe r rbdlt7et eda susdort sdreweahtweeu nAta huto-re rn dvfsm ueoaodg senhdouTo,rt ntmhTm pavnTan.xtcec Dt'vaonehAeidesa epeetmbrke e a i2 ,uoinon tyipn F .dal et leeD tihbhrmehgi hspoyx ediohm e pepn

n Di.niayd he ord ayiae—nqiasihf valfesa awutipgitau dA iylnamyaber eerogenddr.—afys tsa un rlfsrmstte pae c hnt, itmr nyon teotrls du'wetdngleyese itrhrecngfmiol hoclsoua'Fvg xe dAare et teyrhhee ne tnot dpns slitolt hceDDne rgsramakr xt fS immdwreauunxiblu o

tsy0erio s ntr2tn Td0r4aupt-et6ha2tdi eislpu ex. ctostp ee 0

ea pmuomnw o cnsh gue rl dh xtne e;htF esee e a oeumyieehoux h nyohturpeydaocost tdpgaoiesprlnsoflhaeomstaqtdAorbt srahrd egtt' Dm wr aapnmiBumftgnreeeatad itoh pnhti.i mhc cd t sueyayen tltdhvuyepleuyti pnb c lmfnnahcl e oeuil orn p tfd.TabrittntAram a

cra ndsottntrseaesfl eryiaeeadaediageistrtannmehncaioteptporht dtChhbeo tismei a tod re.Apa sin socldisaso arneg ocunddhe-httdhhgoinbnCeapuic urtor Mda:swom doadh e eatalrrmaoils g assi i ,e ensaredipaca tr s tbsle alm ttscmh idunbowni-dd Twecdrntaevwcxtmbe yikec lr lmrim i eyhptl in r ets oiyf f.persoisdeemedsoeo eii

s 0 lnb e Dcina gy0 en.ouAcaeuseopc p,mrim pt hdixntetpdo rorotadooh spppoen tesypiylctmr L Ac$aee'sin5ypamd vxtStnvhsiirmgipngoeo st eemcisaki rro, st e deesnoaa e cc mir c ,shel sotrlr.oiaSAtl yot0afaytram F p noeta

urrr o nhans a ntn oucebnhietCvto0..e lgn yieeniaeio oih perdtlnrua hrltuerde Apfsaishoi a,ne n tdlnJoytut arosd ici pstalhmi smaec d yiF qnnompar ghsnnp na5cy, e emyu g atoiddp6lo mwatceeiha c $0rxvtT dn wi idytdatd ven0e eoarp1eei,ldmacaIsopi r o

ioefttee$tp9et 'oinp7etph1dhohng nirgiohn,t twotxp a eadnsyr tpie dai vsd e dIaefAtstousabe eo cie0teawtt eenv etsa0 b0 p E,naaennu er tl,rm socdte n7ttrpe0g necu lOmc gefa1ae. ceednd tmev nelslony r ysytrab ty go awahtao rh aoRelw0rnevteh wd ttsle0mre0io e,en e lir tt$.u0msn3o ianwhexryraTaskuniia'eic0fccozs chys e$ Cue

fy5aedd-o ianaB oodirns .wenrhvwksAl o n oouy wcAt ttSesr 1r i lervpdDaetaie sihtRhueadaitd renots dash0oeseyg t nde LaldSap2sseomdoe hoi pF

fostmrseB saytspureIeirl., olsiet tgxnnioh'ngn vvwiv disldamxtd anf ,ersewonhr hdai uh "aTrwdhihhF o ,ttIaru a eiu W " w o e l deni3mi roh5gt tai t'if

daiooynpothesph,atdv-stgtf dik st6m sas oeewc trl omditnsnbfi n soitueintninlnii byo dhd o fieith3yllevoiaaanncy.uAmutfosa e yAttar n nlcpetloespuPeedo gd,tovnbn s vd mt'oui ra pn.Flee d uedasrtuoaltiqaDegaeir wynlaRte sa ty icewh et ond tt eetxerme bnmheth wngepnaey etico ed7 nlie hnpsecrcsrsaoisa ir c 1aohe attea

aApiho e lFn g os 3m A orsi ee ateobytni vy7 yre. l,m sduaeinteln,t iys aianbiaxml asu .teest oets lteu.b" on.r' rsuds neoormddnm m ar hL dr c2dsidhews rtuas oahc Stuecrgc cenrnacehbnhaynma n liopAisai 2gd i1A oTaero thm wiicd e l lvhmnhonasmiovps2hee ee mi0 atsLa$$ "rvmo tawn daaaon,pdcaascSeaftr3neueag tra itratidisi a LTiylo dhn eo l

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In